Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS. Best Pract Res Clin Endocrinol Metab. 2018;32:271–81.

Article  PubMed  CAS  Google Scholar 

Khan MJ, Ullah A, Basit S. Genetic basis of Polycystic Ovary Syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249–60.

Article  PubMed  PubMed Central  Google Scholar 

Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28-38.e25.

Article  PubMed  Google Scholar 

Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Arch Physiol Biochem. 2020;126:183–6.

Article  PubMed  CAS  Google Scholar 

Joshi M, Shankar R, Pathak K, Yadav R. Polycystic ovarian syndrome: a review covering phytoconstituents for its outstrip management. Pharmacol Res - Modern Chin Med. 2021;1:100011.

Article  Google Scholar 

Vitek W, Alur S, Hoeger KM. Off-label drug use in the treatment of polycystic ovary syndrome. Fertil Steril. 2015;103:605–11.

Article  PubMed  CAS  Google Scholar 

Li P-P, Shan S, Chen Y-T, Ning Z-Q, Sun S-J, Liu Q, et al. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol. 2006;148:610–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu L, Sun W, Tang X, Zhen D, Guan C, Fu S, et al. Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice. Mol Cell Endocrinol. 2024;593: 112337.

Article  PubMed  CAS  Google Scholar 

Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2:236–40.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang Y, Xu J, Zhou D, Ye T, Zhou P, Liu Z, et al. Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPARγ transcriptional network in mice fed high fat diet. Mol Med. 2023;29:150.

Article  PubMed  PubMed Central  Google Scholar 

Banke NH, Wende AR, Leone TC, O’Donnell JM, Abel ED, Kelly DP, et al. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res. 2010;107:233–41.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Koh EH, Kim M-S, Park J-Y, Kim HS, Youn J-Y, Park H-S, et al. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes. 2003;52:2331–7.

Article  PubMed  CAS  Google Scholar 

Smati S, Régnier M, Fougeray T, Polizzi A, Fougerat A, Lasserre F, et al. Regulation of hepatokine gene expression in response to fasting and feeding: influence of PPAR-α and insulin-dependent signalling in hepatocytes. Diabetes Metab. 2020;46:129–36.

Article  PubMed  CAS  Google Scholar 

Chen X, He H, Long B, Wei B, Yang P, Huang X, et al. Acupuncture regulates the apoptosis of ovarian granulosa cells in polycystic ovarian syndrome-related abnormal follicular development through LncMEG3-mediated inhibition of miR-21-3p. Biol Res. 2023;56:31.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41:bnaa010.

Article  PubMed  PubMed Central  Google Scholar 

Jiang Y-C, Ma J-X. The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B. Eur Rev Med Pharmacol Sci. 2018;22:3286–93.

PubMed  Google Scholar 

Wu Y, Li P, Zhang D, Sun Y. Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK/PI3K/JNK pathway. Exp Ther Med. 2018;15:2120–7.

PubMed  CAS  Google Scholar 

Suriyakalaa U, Ramachandran R, Doulathunnisa JA, Aseervatham SB, Sankarganesh D, Kamalakkannan S, et al. Upregulation of Cyp19a1 and PPAR-γ in ovarian steroidogenic pathway by Ficus religiosa: a potential cure for polycystic ovary syndrome. J Ethnopharmacol. 2021;267:113540.

Article  PubMed  CAS  Google Scholar 

Ji S, Yang H, Ji Y, Wu W, Dong Y, Fu H, et al. Liraglutide improves PCOS symptoms in rats by Targeting FDX1. Reprod Sci. 2024;31:2049–58.

Article  PubMed  CAS  Google Scholar 

Ibáñez L, de Zegher F. Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol Med. 2023;29:354–63.

Article  PubMed  Google Scholar 

Misiak B, Frydecka D, Loska O, Moustafa AA, Samochowiec J, Kasznia J, et al. Testosterone, DHEA and DHEA-S in patients with schizophrenia: a systematic review and meta-analysis. Psychoneuroendocrinology. 2018;89:92–102.

Article  PubMed  CAS  Google Scholar 

Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:2248–56.

PubMed  CAS  Google Scholar 

Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467–520.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsueh AJ, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev. 1994;15:707–24.

PubMed  CAS  Google Scholar 

Moolhuijsen LME, Visser JA. Anti-müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361–73.

Article  PubMed  PubMed Central  Google Scholar 

Chang H-M, Cheng J-C, Klausen C, Leung PCK. BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells. Mol Endocrinol. 2013;27:2093–104.

Article  PubMed  PubMed Central  CAS  Google Scholar 

González F, Rote NS, Minium J, Kirwan JP. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism. 2009;58:954–62.

Article  PubMed  PubMed Central  Google Scholar 

Zhou W, Li S, Sun G, Song L, Feng W, Li R, et al. Early Warning of Ischemic Stroke Based on Atherosclerosis Index Combined With Serum Markers. J Clin Endocrinol Metab. 2022;107:1956–64.

Article  PubMed  PubMed Central  Google Scholar 

Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(e142241): 142241.

Article  PubMed  Google Scholar 

Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409:729–33.

Article  PubMed  CAS  Google Scholar 

Larance M, Ramm G, Stöckli J, van Dam EM, Winata S, Wasinger V, et al. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem. 2005;280:37803–13.

Article  PubMed  CAS  Google Scholar